Youth Bio Global Co., Ltd. (CEO Yoo Seung-ho) participated in the ‘BIO KOREA 5 (Bio Korea 10) Conference’ held at COEX, Seoul for three days from May 12th (Wed) to 3th (Fri), business partnering, investment fair He said that he had achieved the desired results by actively participating in various events such as the announcement of the technology he possessed.
In this regard, Jiyoung Jang, head of the research institute, said that the company is currently pushing for entry into overseas markets such as the United States, and in particular, discussed establishing a patent strategy with the Institute for Patent Strategy Development and the Korea Invention Promotion Association to secure patent rights in the United States. In addition, it added that it had agreed to continue an additional meeting based on excellence and interest in the technology it possesses through business partnering with Boehringer Ingelheim of Japan. At the same time, through partnering with Germany’s CATALENT, we plan to discuss cooperation plans in detail in the US market, and we plan to continue discussions with Japan’s iHEART for collaboration.
CEO Yoo Seung-ho attended the technology presentation session at the conference and even announced plans to make finished medicines for cell culture media, wound dressings, and ischemic vascular treatments based on compositions and culture technologies that can enhance and enhance biological activity.
In addition, through panel discussions with Yuanta Securities, etc., at a positive time when the corona pandemic is over and transitioning to endemic, the need to rationalize investment trends in the bioindustry and related government regulations, as well as full-fledged efforts to vitalize clinical trials Active discussions were held on areas where support was desperately needed.
Youth Bio Global announced that it plans to participate in various programs and partnering by attending BIO USA held in Boston, USA in early June after being selected as one of the ‘Super Gap Companies 1000’.
Meanwhile, ‘BIO KOREA 18’, which celebrated its 2023th anniversary this year, was hosted by the Korea Health Industry Development Institute and Chungcheongbuk-do. BIO KOREA, which has been striving to improve the global status and sustainable growth of the Korean health industry since 2006, is solidifying its position as Korea’s representative biohealth international convention with the participation of world-class scholars and business experts every year. BIO KOREA 2023, in collaboration with companies related to the health industry such as domestic and foreign bio, pharmaceuticals, medical devices, cosmetics, and food, as well as interested companies and institutions such as consulting, academia, and related organizations, will be held through various programs such as conferences, business partnering, exhibitions, and investment fairs. It went ahead.